Training the Next Generation: 2026 JING Cohort Launches in Manchester

At the end of January, the ECMC to present their own study ideas, receiving feedback from faculty and peers. Congratulations to the winners of the best study idea in each group!

At the end of January, the ECMC Network gathered in Manchester for our annual Training the Next Generation event – an inspiring two‑day programme designed for early career investigators across the UK. This event marks the official launch of the 2026 Junior Investigator Network Group (JING) Cohort, setting the stage for a year of learning, collaboration and skills development.

Looking Ahead: Webinars for the Wider JING Community

Throughout 2026, we will be hosting a series of webinars to continue supporting the development of the JING cohort. These sessions will also be open to the wider JING community — so please keep an eye out for further details.

For more information about the Training the Next Generation programme or the JING cohort, please contact Hannah Brown in the ECMC Programme Office.

This year’s cohort is our largest yet, with over 60 trainees nominated by their ECMC Leads. We were also delighted to welcome three researchers from the UK Clinical Research Facility Network, opening the door for early career colleagues working in early phase cancer research beyond the ECMC Network to join the programme.

Two Days of Learning, Discussion and Inspiration

Across the event, trainees heard from a range of expert speakers covering topics essential to early phase cancer research. Sessions included:

• collaborating effectively with industry and Clinical Trials Units
• understanding the role and application of statistics
• an in‑depth trial case study sharing practical lessons learned

Small‑group activities allowed trainees to explore their research interests, discuss career pathways and connect directly with peers. They were supported throughout by our committed faculty of senior clinicians, scientists, statisticians and patient representatives, each offering valuable insight and experience.

Embedding Patient and Public Involvement

Day two focused on patient and public involvement (PPI) – a core component of high‑quality research. Trainees took part in facilitated discussions on writing an accessible lay summary and exploring meaningful ways to involve people affected by cancer in research design and delivery.